Improving Diabetes Management Through HbA1c Testing
A new program boosts HbA1c testing quality in primary care settings.
Pan Liping, Yang Jun, Luo Kun, Yun Hao, Wei Shen, Tan Jin, Lin Ming
― 6 min read
Table of Contents
Diabetes Mellitus is a health issue that affects many people around the world. It is a condition that can lead to serious health problems and, sadly, many deaths every year. According to reports, the number of people who die from diabetes has been increasing steadily. Over a period of nearly two decades, the number of deaths attributed to this condition rose by 3%. In 2019 alone, diabetes was responsible for 1.5 million deaths.
HbA1c?
What isOne of the key tests used to monitor diabetes is called the HbA1c test. This test measures the average blood sugar levels in a person over the last two to three months. The higher the HbA1c percentage, the poorer the blood sugar control. Since 2011, a result of 6.5% or higher has been used as a marker for diagnosing diabetes. This makes HbA1c an essential tool for doctors in managing and tracking the progress of diabetes.
Standardization
The Need forInterestingly, there are many different devices and methods to measure HbA1c, leading to varying results across different medical laboratories. This inconsistency can create confusion for patients and doctors alike. For doctors to make the best decisions for their patients, it's crucial that test results are consistent and comparable between different labs. Furthermore, having a high-quality and standardized HbA1c test is vital for ensuring that hospitals can recognize each other's test results.
Primary Care's Role in Diabetes Management
In many regions, primary care doctors and local medical facilities are the frontline for treating chronic illnesses, including diabetes. These Primary Healthcare providers often handle many patients and deal with various health issues. To successfully use the HbA1c test over time, there's a need for strict Quality Control. This includes making sure laboratories are accredited, having robust internal checks, and participating in external quality assessments.
However, a study showed that variations in HbA1c test results among different hospitals could be as high as 20%. With some primary medical facilities not equipped or prepared for such Testing, the quality of these tests in less affluent areas could be even worse.
Starting a Comparison Program
To tackle this issue, a research team initiated a comparison program for HbA1c tests among various laboratories in Wuhan, China. Their goal was to evaluate how consistent the results were across different facilities and improve the quality of diabetes testing at local clinics.
How It Worked
Eighty laboratories from 51 primary healthcare institutions and 29 tertiary medical institutions were involved in the program. Every three months, participating labs received 10 samples for free and submitted their results to a central evaluation platform.
The samples used were leftover blood samples from everyday clinical tests. They were carefully prepared, making sure they were suitable for testing. Abnormal samples were removed to ensure accurate results. These samples were stored properly and sent to different labs for testing.
The Results of the Program
The program took place over two years, allowing the researchers to track progress. Each quarter, the labs compared their results against target values established by a certified laboratory. They were measured against a strict standard, which required them to have results within 6% of the target value.
Surprisingly, the initial pass rate for primary healthcare institutions was only about 39.2%, but by the end of the program, it improved to 64.6%. This is like going from a failing grade to a solid C!
Different Testing Methods
Different labs used various methods for testing HbA1c, including advanced techniques like High-Performance Liquid Chromatography (HPLC) and simpler methods like immunoassays. In larger hospitals, HPLC was the most common method, while primary healthcare facilities were using a mix of methods, including some not as reliable.
Among the primary healthcare labs, the methods differed. For instance, more than a third used HPLC methods, while others relied on immunofluorescence or Point-of-Care Testing (POCT). Interestingly, the tests done using immunoassays showed a lot of variation, which dropped over the study period due to improved training and guidelines.
The Importance of Quality Control
The study found that the key to reliable HbA1c results is quality control. Many primary care facilities struggle with financial limits, lack of trained staff, and outdated equipment. Because of this, the test results can be less trustworthy than those from larger hospitals.
Even though POCT devices are convenient for quick tests, their accuracy often falls short of standard laboratory equipment, leading doctors to treat them more as monitoring tools than diagnostic tests.
Keeping Up with Standards
A national effort to standardize HbA1c testing began in 2020, aiming to ensure that measurements are consistent across different laboratories. This program emphasizes the importance of continual improvement in testing quality to provide better care for diabetes patients.
By the end of the comparison program, the HbA1c tests in primary health institutions showed a marked improvement, with a notable drop in the variability of results. Despite this, the study concluded that many testing methods still do not meet clinical standards, indicating that there is more work to be done on enhancing the reliability of these tests.
Future Directions
While the program showed initial success, there are still limitations. Only one lab was involved in determining the comparison specimen values, and in the future, it would be beneficial to collaborate with additional qualified partners. Moreover, since only a fraction of primary healthcare facilities routinely performed HbA1c testing, expanding its use under strict quality control could lead to better management of diabetes.
Conclusion
In sum, improving the accuracy and consistency of HbA1c testing is vital for better diabetes management. The research conducted in Wuhan provides hope and a practical example of how ongoing assessments can lead to better testing quality in primary healthcare settings. By working together and continuously monitoring data, healthcare providers can help ensure that diabetes patients receive the best possible care.
And who knows? With a little persistence, maybe one day, doctors will have the same confidence in primary healthcare test results as they do in their favorite coffee shop’s ability to produce a perfect cup of coffee every time!
Original Source
Title: Inter-laboratory comparison of HbA1c can effectively improve test consistency of primary medical institutions
Abstract: BackgroundGlycated hemoglobin (HbA1c) represents a diagnostic index and an important long-term measure for monitoring Diabetes mellitus (DM). In this study, we investigated the quality of HBA1c test in primary medical institutions, and conducted a comparison project of HBA1c test for two years, analyzed and evaluated the test consistency of HBA1c. MethodsA cohort study was conducted by Wuhan Center for Clinical Laboratory, involving 51 primary medical institutions and 29 tier-three hospitals. Fresh frozen blood samples were prepared by a clinical laboratory certificated by the National Glycohemoglobin Standardization Program (NGSP), and distributed to 80 participating institutions every three months. Microsoft Excel 2021 software was employed to analyze the mean, standard deviation and coefficient of variation of the test results. ResultsResults showed that 60.8% HBA1c test results cannot reach the quality requirements of HbA1c measurement (CV
Authors: Pan Liping, Yang Jun, Luo Kun, Yun Hao, Wei Shen, Tan Jin, Lin Ming
Last Update: 2024-12-29 00:00:00
Language: English
Source URL: https://www.medrxiv.org/content/10.1101/2024.12.27.24319677
Source PDF: https://www.medrxiv.org/content/10.1101/2024.12.27.24319677.full.pdf
Licence: https://creativecommons.org/licenses/by/4.0/
Changes: This summary was created with assistance from AI and may have inaccuracies. For accurate information, please refer to the original source documents linked here.
Thank you to medrxiv for use of its open access interoperability.